Institut Carnot Curie Cancer

WHAT IS INSTITUT CARNOT CURIE CANCER?

• A CLEAR COMMITMENT

Ensure scientific production prepare the responses of tomorrow
Improve professionalism
Develop socio-economic partnerships
Foster network-based functioning of the Carnot institutes

• A SOURCE OF STRENGTH FOR OUR INSTITUTE

A major national multi-disciplinary research network, building economic development through technologies and innovation
Financial support for scientific sourcing
A recognized label of excellence

• AN ASSET FOR INDUSTRIAL PARTNERS

A token of quality for high scientific standards
Professionalism and their commitment to developing high quality partnership research
Capacity to anticipate market needs
Access to and attentiveness from experts
Commitment to competitiveness

FROM THERAPEUTIC TARGET TO CLINICAL VALIDATION

Institut Carnot Curie Cancer offers industrial partners the possibility to set up research collaborations to go from the identification of a therapeutic target to the clinical validation of a drug. For Institut Curie, the Carnot label is a token of:

• Expertise
  Institut Curie must maintain world-class expertise in the field of oncology. The Carnot initiative makes it possible to gather the critical mass needed to create leverage and drive this state-of-the-art research dynamic.

• Collaborations
  Institut Curie must position itself to focus on the exchange of expertise and know-how. The Carnot initiative allows for transverse projects that encourage this.

SOURCING INNOVATIVE PROJECTS

The Carnot initiative supports innovative projects that otherwise would not be funded. The data collected reduce investment risks of others funding sources that would take in charge the next steps of the most promising opportunities. Carnot institutes network represents 50% of the national activity in partnership research now brings together more than 13,000 researchers.